Loperamide-Induced Acute Pancreatitis-Reference-Cited by-同舟云学术

Loperamide-Induced Acute Pancreatitis

Published:2013 Issue: Volume:2013 Page:1-2
ISSN:2090-6528
Container-title:Case Reports in Gastrointestinal Medicine
language:en
Short-container-title:Case Reports in Gastrointestinal Medicine

Author:

Vidarsdottir Halla¹^ORCID,Vidarsdottir Hanna²,Moller Pall Helgi³⁴,Bjornsson Einar Stefan⁴⁵

Affiliation:

1. Department of Surgery, Helsingborg Hospital, 25187 Helsingborg, Sweden

2. Department of Anaesthesiology and Intensive Care, Landspitali University Hospital, 101 Reykjavik, Iceland

3. Department of Surgery, Landspitali University Hospital, 101 Reykjavik, Iceland

4. Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland

5. Department of Gastroenterology, Landspitali University Hospital, 101 Reykjavik, Iceland

Abstract

Acute pancreatitis is a common disease leading to hospitalizations, most often caused by gallstones or alcohol. We present a case of a patient diagnosed with acute pancreatitis considered to be due to loperamide treatment for diarrhea.

Publisher

Hindawi Limited

Subject

General Engineering

Link

http://downloads.hindawi.com/journals/crigm/2013/517414.pdf

Reference10 articles.

1. Acute pancreatitis: a prospective study of its incidence, aetiology, severity, and mortality in Iceland

2. Time trends in incidence, etiology, and case fatality rate of the first attack of acute pancreatitis

3. Drug-Induced Pancreatitis

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of irritable bowel syndrome with diarrhea: focus on eluxadoline;Current Medical Research and Opinion;2021-03-03

2. Loperamide Abuse and Its Sequelae;American Journal of Forensic Medicine & Pathology;2020-09

3. Increased Risk of Acute Pancreatitis with Codeine Use in Patients with a History of Cholecystectomy;Digestive Diseases and Sciences;2019-08-29

4. Review article: an analysis of safety profiles of treatments for diarrhoea-predominant irritable bowel syndrome;Alimentary Pharmacology & Therapeutics;2018-09-07

5. Risk of Pancreatitis Following Treatment of Irritable Bowel Syndrome With Eluxadoline;Clinical Gastroenterology and Hepatology;2018-03